Azzaroli F - Search Results

1

Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers.

Mazzella G, Rizzo N, Azzaroli F, Simoni P, Bovicelli L, Miracolo A, Simonazzi G, Colecchia A, Nigro G, Mwangemi C, Festi D, Roda E. Mazzella G, et al. Among authors: azzaroli f. Hepatology. 2001 Mar;33(3):504-8. doi: 10.1053/jhep.2001.22647. Hepatology. 2001. PMID: 11230728 Clinical Trial.

2

Predictors of non-transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection.

Pelizzaro F, Trevisani F, Simeon V, Vitale A, Cillo U, Piscaglia F, Missale G, Sangiovanni A, Foschi FG, Cabibbo G, Caturelli E, Di Marco M, Azzaroli F, Brunetto MR, Raimondo G, Vidili G, Guarino M, Gasbarrini A, Campani C, Svegliati-Baroni G, Giannini EG, Mega A, Masotto A, Rapaccini GL, Magalotti D, Sacco R, Nardone G, Farinati F; Italian Liver Cancer (ITA.LI.CA) group. Pelizzaro F, et al. Among authors: azzaroli f. Liver Int. 2023 Dec;43(12):2762-2775. doi: 10.1111/liv.15719. Epub 2023 Sep 27. Liver Int. 2023. PMID: 37753540

3

Sorafenib and Metronomic Capecitabine in Child-Pugh B patients with advanced HCC: A real-life comparison with best supportive care.

Stefanini B, Bucci L, Santi V, Reggidori N, Lani L, Granito A, Pelizzaro F, Cabibbo G, Di Marco M, Ghittoni G, Campani C, Svegliati-Baroni G, Foschi FG, Giannini EG, Biasini E, Saitta C, Magalotti D, Sangiovanni A, Guarino M, Gasbarrini A, Rapaccini GL, Masotto A, Sacco R, Vidili G, Mega A, Azzaroli F, Nardone G, Brandi G, Sabbioni S, Vitale A, Trevisani F. Stefanini B, et al. Among authors: azzaroli f. Dig Liver Dis. 2024 Sep;56(9):1582-1591. doi: 10.1016/j.dld.2024.01.199. Epub 2024 Feb 9. Dig Liver Dis. 2024. PMID: 38341377

4

[Intrahepatic cholestasis in chronic liver disease].

Roda E, Pezzoli A, Fusaroli P, Fabbri C, Jaboli F, Marchetto S, Azzaroli F, Mazzella G. Roda E, et al. Among authors: azzaroli f. Ann Ital Med Int. 1996 Oct;11 Suppl 2:48S-52S. Ann Ital Med Int. 1996. PMID: 9004820 Review. Italian.

5

Long-term results with interferon therapy in chronic type B hepatitis: a prospective randomized trial.

Mazzella G, Saracco G, Festi D, Rosina F, Marchetto S, Jaboli F, Sostegni R, Pezzoli A, Azzaroli F, Cancellieri C, Montagnani M, Roda E, Rizzetto M. Mazzella G, et al. Among authors: azzaroli f. Am J Gastroenterol. 1999 Aug;94(8):2246-50. doi: 10.1111/j.1572-0241.1999.01300.x. Am J Gastroenterol. 1999. PMID: 10445557 Clinical Trial.

6

Sluggish small bowel motility is involved in determining increased biliary deoxycholic acid in cholesterol gallstone patients.

Azzaroli F, Mazzella G, Mazzeo C, Simoni P, Festi D, Colecchia A, Montagnani M, Martino C, Villanova N, Roda A, Roda E. Azzaroli F, et al. Am J Gastroenterol. 1999 Sep;94(9):2453-9. doi: 10.1111/j.1572-0241.1999.01375.x. Am J Gastroenterol. 1999. PMID: 10484008

7

Methylprednisolone administration in primary biliary cirrhosis increases cholic acid turnover, synthesis, and deoxycholate concentration in bile.

Mazzella G, Fusaroli P, Pezzoli A, Azzaroli F, Mazzeo C, Zambonin L, Simoni P, Festi D, Roda E. Mazzella G, et al. Among authors: azzaroli f. Dig Dis Sci. 1999 Dec;44(12):2478-83. doi: 10.1023/a:1026687022202. Dig Dis Sci. 1999. PMID: 10630500

8

Efficacy of ursodeoxycholic acid in association with alpha-interferon for chronic hepatitis C in alpha-interferon non-responder patients.

Fabbri C, Marchetto S, Pezzoli A, Accogli E, Fusaroli P, Azzaroli F, Jaboli MF, Mazzeo C, Montagnani M, Festi D, Roda E, Mazzella G. Fabbri C, et al. Among authors: azzaroli f. Eur J Gastroenterol Hepatol. 2000 May;12(5):511-5. doi: 10.1097/00042737-200012050-00006. Eur J Gastroenterol Hepatol. 2000. PMID: 10833093 Clinical Trial.

9

Competition in liver transport between chenodeoxycholic acid and ursodeoxycholic acid as a mechanism for ursodeoxycholic acid and its amidates' protection of liver damage induced by chenodeoxycholic acid.

Piazza F, Montagnani M, Russo C, Azzaroli F, Aldini R, Roda E, Roda A. Piazza F, et al. Among authors: azzaroli f. Dig Liver Dis. 2000 May;32(4):318-28. doi: 10.1016/s1590-8658(00)80025-0. Dig Liver Dis. 2000. PMID: 11515630

10

The UDCA dosage deficit: a fate shared with CDCA.

Roda E, Liva S, Ferrara F, Azzaroli F, Giovanelli S, Nigro G, Festi D, Mazzella G. Roda E, et al. Among authors: azzaroli f. Eur J Gastroenterol Hepatol. 2002 Mar;14(3):213-6. doi: 10.1097/00042737-200203000-00002. Eur J Gastroenterol Hepatol. 2002. PMID: 11953683

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113 results

Search Page

Filters